ESMO : Breakthroughs in Melanoma Treatment Regimens
https://www.medscape.com/viewarticle/1000475
Web3 days ago · The rate was significantly inferior if you got targeted therapy first, at 56%. Unfortunately, if you look at survival after developing brain metastases, if you only go to, say, 24 months, it's ...
DA: 68 PA: 55 MOZ Rank: 27